Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Sales | 434,925 | 402,062 | 415,605 | 382,653 | 442,646 |
| Cost of Goods | 214,060 | 195,071 | 206,273 | 188,221 | 193,574 |
| Gross Profit | 220,865 | 206,991 | 209,332 | 194,432 | 249,072 |
| Operating Expenses | 197,885 | 195,301 | 722,279 | 210,150 | 214,020 |
| Operating Income | 23,040 | 11,761 | -512,674 | -15,497 | 35,626 |
| Interest Expense | 23,673 | 22,725 | 21,042 | 18,815 | 18,984 |
| Other Income | 4,943 | 4,140 | 2,764 | 4,276 | 5,898 |
| Pre-tax Income | 4,310 | -6,824 | -530,952 | -30,036 | 22,540 |
| Income Tax | 6,014 | -1,420 | -46,879 | -4,743 | 3,106 |
| Net Income Continuous | -1,704 | -5,404 | -484,073 | -25,293 | 19,434 |
| Net Income | $-1,704 | $-5,404 | $-484,073 | $-25,293 | $19,434 |
| EPS Basic Total Ops | -0.03 | -0.07 | -6.31 | -0.33 | 0.25 |
| EPS Basic Continuous Ops | -0.02 | -0.07 | -6.31 | -0.33 | 0.25 |
| EPS Diluted Total Ops | -0.03 | -0.07 | -6.31 | -0.33 | 0.25 |
| EPS Diluted Continuous Ops | -0.02 | -0.07 | -6.31 | -0.33 | 0.25 |
| EPS Diluted Before Non-Recurring Items | 0.83 | 0.54 | 0.45 | 0.41 | 0.97 |
| EBITDA(a) | $62,485 | $51,598 | $-473,092 | $23,076 | $74,615 |